Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 3
1999 1
2000 2
2001 1
2002 1
2003 3
2004 2
2005 2
2006 6
2007 3
2008 22
2009 40
2010 36
2011 60
2012 96
2013 110
2014 183
2015 145
2016 129
2017 107
2018 86
2019 75
2020 66
2021 42
Text availability
Article attribute
Article type
Publication date

Search Results

1,042 results
Results by year
Filters applied: . Clear all
Page 1
LC-MS-based metabolomics.
Zhou B, Xiao JF, Tuli L, Ressom HW. Zhou B, et al. Mol Biosyst. 2012 Feb;8(2):470-81. doi: 10.1039/c1mb05350g. Epub 2011 Nov 1. Mol Biosyst. 2012. PMID: 22041788 Free PMC article. Review.
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects.
Verma V, Jafarzadeh N, Boi S, Kundu S, Jiang Z, Fan Y, Lopez J, Nandre R, Zeng P, Alolaqi F, Ahmad S, Gaur P, Barry ST, Valge-Archer VE, Smith PD, Banchereau J, Mkrtichyan M, Youngblood B, Rodriguez PC, Gupta S, Khleif SN. Verma V, et al. Nat Immunol. 2021 Jan;22(1):53-66. doi: 10.1038/s41590-020-00818-9. Epub 2020 Nov 23. Nat Immunol. 2021. PMID: 33230330
Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.
Salamone JM, Lucas W, Brundage SB, Holloway JN, Stahl SM, Carbine NE, London M, Greenwood N, Goyes R, Chisholm DC, Price E, Carlin R, Winarsky S, Baker KB, Maues J, Shajahan-Haq AN. Salamone JM, et al. Cancer Res. 2018 Oct 15;78(20):5723-5728. doi: 10.1158/0008-5472.CAN-18-1600. Epub 2018 Aug 17. Cancer Res. 2018. PMID: 30120210 Free PMC article. Review.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.
Swain SM, Kim SB, Cortés J, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Knott A, Clark E, Ross G, Benyunes MC, Baselga J. Swain SM, et al. Lancet Oncol. 2013 May;14(6):461-71. doi: 10.1016/S1470-2045(13)70130-X. Epub 2013 Apr 18. Lancet Oncol. 2013. PMID: 23602601 Free PMC article. Clinical Trial.
Emerging themes in cohesin cancer biology.
Waldman T. Waldman T. Nat Rev Cancer. 2020 Sep;20(9):504-515. doi: 10.1038/s41568-020-0270-1. Epub 2020 Jun 8. Nat Rev Cancer. 2020. PMID: 32514055 Review.
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Peran I, Dakshanamurthy S, McCoy MD, Mavropoulos A, Allo B, Sebastian A, Hum NR, Sprague SC, Martin KA, Pishvaian MJ, Vietsch EE, Wellstein A, Atkins MB, Weiner LM, Quong AA, Loots GG, Yoo SS, Assefnia S, Byers SW. Peran I, et al. Gastroenterology. 2021 Mar;160(4):1359-1372.e13. doi: 10.1053/j.gastro.2020.11.044. Epub 2020 Dec 9. Gastroenterology. 2021. PMID: 33307028
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.
Lynce F, Barac A, Geng X, Dang C, Yu AF, Smith KL, Gallagher C, Pohlmann PR, Nunes R, Herbolsheimer P, Warren R, Srichai MB, Hofmeyer M, Cunningham A, Timothee P, Asch FM, Shajahan-Haq A, Tan MT, Isaacs C, Swain SM. Lynce F, et al. Breast Cancer Res Treat. 2019 Jun;175(3):595-603. doi: 10.1007/s10549-019-05191-2. Epub 2019 Mar 9. Breast Cancer Res Treat. 2019. PMID: 30852761 Free PMC article. Clinical Trial.
1,042 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page